Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study.
Saved in:
| Title: | Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study. |
|---|---|
| Authors: | Davarpanah MA; Shiraz HIV/AIDS Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Adatorwovor R; Department of Biostatistics, University of Kentucky, Lexington, KY, USA., Mansoori Y; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran., Ramsheh FSR; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran., Parsa A; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran., Hajiani M; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran., Faramarzi H; Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Kavuluru R; Division of Biomedical Informatics, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA., Asadipooya K; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Barnstable Brown Diabetes and Obesity Center, University of Kentucky, 2195 Harrodsburg Rd, Suite 125, Lexington, KY, 40504, USA. kas224@uky.edu. |
| Source: | Journal of endocrinological investigation [J Endocrinol Invest] 2024 Jan; Vol. 47 (1), pp. 235-243. Date of Electronic Publication: 2023 Jun 24. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1720-8386 (Electronic) Linking ISSN: 03914097 NLM ISO Abbreviation: J Endocrinol Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
